USA - NYSEARCA:XTNT - US98420P3082 - Common Stock
Overall XTNT gets a fundamental rating of 3 out of 10. We evaluated XTNT against 190 industry peers in the Health Care Equipment & Supplies industry. XTNT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, XTNT is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -4.43% | ||
ROE | -9.44% | ||
ROIC | 0.03% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 0.02% | ||
PM (TTM) | N/A | ||
GM | 60.16% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.46 | ||
Debt/FCF | N/A | ||
Altman-Z | -0.51 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.47 | ||
Quick Ratio | 1.16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 153.33 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 30.42 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.782
+0 (+0.26%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 153.33 | ||
P/S | 0.86 | ||
P/FCF | N/A | ||
P/OCF | 72.94 | ||
P/B | 2.26 | ||
P/tB | 3.25 | ||
EV/EBITDA | 30.42 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -4.43% | ||
ROE | -9.44% | ||
ROCE | 0.04% | ||
ROIC | 0.03% | ||
ROICexc | 0.03% | ||
ROICexgc | 0.04% | ||
OM | 0.02% | ||
PM (TTM) | N/A | ||
GM | 60.16% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.46 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 4.97 | ||
Cap/Depr | 97.07% | ||
Cap/Sales | 3.39% | ||
Interest Coverage | 0.01 | ||
Cash Conversion | 33.42% | ||
Profit Quality | N/A | ||
Current Ratio | 2.47 | ||
Quick Ratio | 1.16 | ||
Altman-Z | -0.51 |